MEF2A and coronary artery disorder: Our findings show that numerous genes in inflammatory pathways were down-regulated as MEF2A was silenced, indicating that MEF2A may be an important regulator to mediate the expression of inflammatory factors, and that this role of MEF2A appears to be inconsistent with its protective effect against CAD.